We & Win Diversification Co., Ltd.
Taipei Exchange 4113.TWO
We & Win Diversification Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 21.08%
We & Win Diversification Co., Ltd. Gross Profit Margin is 21.08% for the year ending December 31, 2023, a -33.42% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
We & Win Diversification Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 31.67%, a 25.04% change year over year.
-
We & Win Diversification Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 25.33%, a 22.78% change year over year.
-
We & Win Diversification Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 20.63%, a -18.67% change year over year.
-
We & Win Diversification Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 25.36%.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Taipei Exchange: 4113.TWO
| CEO | Mr. Yung-Yi Su |
| IPO Date | Dec. 31, 2007 |
| Location | |
| Headquarters | No. 185, Fuguo Road |
| Employees | 35 |
| Sector | Consumer Staples |
| Industries | |
Description
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email